Shine-On BioMedical Co.,Ltd. (TPEX:6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
66.00
-2.30 (-3.37%)
At close: Feb 26, 2026
0.76%
Market Cap 3.29B
Revenue (ttm) n/a
Net Income (ttm) -117.07M
Shares Out 49.80M
EPS (ttm) -2.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 39,298
Average Volume 13,914
Open 67.90
Previous Close 68.30
Day's Range 63.10 - 68.00
52-Week Range 57.00 - 81.60
Beta -0.03
RSI 36.58
Earnings Date Nov 14, 2025

About Shine-On BioMedical

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. Shine-On BioMedical Co.,Ltd. was founded in 2011 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.